EUVIMEDEUVIMED entdecken
Crossref

Molecular Crosstalk between Artificial Sweetener Aspartame and Diabetes-Linked Insulin Hormone Unveils Possible Amyloidosis Risks

Masihuzzaman Ansari iD, Kailash Prasad Prajapati iD, Shikha Mittal, Vaishali Bhati, Vartika Gupta, Shraddha Mishra, Swati Patidar, Om Prakash Mahato iD, Aurgha Kamal Bhandari, Bibin Gnanadhason Anand iD, Karunakar Kar iD

Biomacromolecules · 2025

DOI: 10.1021/acs.biomac.5c00286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Masihuzzaman Ansari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biophysical and Biomaterials Research Laboratory, Room 310, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India. Hauptthemen laut MEDLINE: Aspartame, Sweetening Agents, Insulin, Amyloidosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An important adaptation for diabetes patients is the consumption of artificial sweetener aspartame, which is present in more than thousands of food products and medicines. Several studies have shown diverse side effects of aspartame, and it is also known to form amyloid-like cytotoxic and cross-seeding-competent nanostructures. Here, we reveal a direct crosstalk between aspartame and insulin that induces their cross-seeding and coaggregation events. Insulin’s cross-β structure possesses high affinity for aspartame and triggers its self-assembly into cytotoxic nanostructures. Likewise, aspartame nanostructures were found to trigger the amyloid aggregation of insulin. The coaggregates of aspartame and insulin display amyloid-like structural and biophysical characteristics, and possess potential to initiate cross-seeding reactions. Importantly, unlike insulin fibrils, the aspartame–insulin coassembled fibrils were found to be peptidase-resistant and cytotoxic. The results indicate the interplay between insulin fibrillation and aspartame aggregation, which signifies a possible link between the progression of diabetes-associated complications and the consumption of aspartame.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspartameSweetening AgentsInsulinAmyloidosisDiabetes MellitusHumansAmyloid

Substanzen

AspartameSweetening AgentsInsulinAmyloid

Autor:innen und Institutionen

  • Biophysical and Biomaterials Research Laboratory, Room 310, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
  • Biomolecular Self-Assembly Lab, Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603203, India.

ORCID-Profile: Masihuzzaman Ansari, Kailash Prasad Prajapati, Om Prakash Mahato, Bibin Gnanadhason Anand, Karunakar Kar

Zitieren

APA

Ansari, M., Prajapati, K. P., Mittal, S., Bhati, V., Gupta, V., Mishra, S., Patidar, S., Mahato, O. P., Bhandari, A. K., Anand, B. G., & Kar, K. (2025). Molecular Crosstalk between Artificial Sweetener Aspartame and Diabetes-Linked Insulin Hormone Unveils Possible Amyloidosis Risks. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c00286

Vancouver

Ansari M, Prajapati KP, Mittal S, Bhati V, Gupta V, Mishra S, et al. Molecular Crosstalk between Artificial Sweetener Aspartame and Diabetes-Linked Insulin Hormone Unveils Possible Amyloidosis Risks. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c00286

BibTeX
@article{Ansari2025,
  author = {Ansari, Masihuzzaman and Prajapati, Kailash Prasad and Mittal, Shikha and Bhati, Vaishali and Gupta, Vartika and Mishra, Shraddha and Patidar, Swati and Mahato, Om Prakash and Bhandari, Aurgha Kamal and Anand, Bibin Gnanadhason and Kar, Karunakar},
  title = {Molecular Crosstalk between Artificial Sweetener Aspartame and Diabetes-Linked Insulin Hormone Unveils Possible Amyloidosis Risks},
  journal = {Biomacromolecules},
  year = {2025},
  doi = {10.1021/acs.biomac.5c00286}
}
Kostenlos starten →